Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen.

C-H Yang1, H-C Ho, Y-S Chan

  • 1Department of Dermatology, Chang Gung Memorial Hospital, 199 Tun Hwa North Road, Taipei, Taiwan.

The British Journal of Dermatology
|September 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parecoxib prevents nucleus pulposus cells apoptosis by suppressing endoplasmic reticulum stress.

European review for medical and pharmacological sciences·2020
Same author

Revisit three "I" model: a novel five "I" model of fracture liaison service.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

The gelling effect of platelet-rich fibrin matrix when exposed to human tenocytes from the rotator cuff in small-diameter culture wells and the design of a co-culture device to overcome this phenomenon.

Bone & joint research·2019
Same author

LncRNA SNHG8 participates in the development of endometrial carcinoma through regulating c-MET expression by miR-152.

European review for medical and pharmacological sciences·2018
Same author

Optimizing the electromechanical response in morphotropic BiFeO<sub>3</sub>.

Nanotechnology·2018
Same author

The MNS glycophorin variant GP.Mur affects differential erythroid expression of Rh/RhAG transcripts.

Vox sanguinis·2017

Hyperbaric oxygen therapy (HBOT) offers a promising new treatment for livedoid vasculopathy, effectively healing painful ulcers and resolving associated pain in resistant cases. This novel approach shows significant potential for patients with this challenging condition.

Area of Science:

  • Vascular Medicine
  • Dermatology
  • Wound Healing

Background:

  • Livedoid vasculopathy presents as chronic, painful ulcers on lower extremities with dermal vessel occlusion and no effective treatments.
  • Current therapeutic options for livedoid vasculopathy are limited and often unsatisfactory.

Observation:

  • Two patients with therapy-resistant livedoid vasculopathy were treated with hyperbaric oxygen (HBOT).
  • Lesions in both patients showed rapid ulcer response and significant reduction in wound pain following HBOT.

Findings:

  • This study reports the first successful trial of HBOT for livedoid vasculopathy.
  • HBOT demonstrated rapid healing of ulcers and effective pain resolution in patients with this condition.

Implications:

Related Experiment Videos

  • Hyperbaric oxygen therapy is a promising new treatment modality for livedoid vasculopathy.
  • Further investigation into HBOT for livedoid vasculopathy is warranted due to its potential efficacy.